Secondary Logo

Journal Logo

August 2005 - Volume 28 - Issue 4
pp: 327-432


A Phase II Study of Intravenous Exatecan Administered Daily for 5 Days, Every 3 Weeks to Patients With Biliary Tract Cancers

Abou-Alfa, Ghassan K.; Rowinsky, Eric K.; Patt, Yehuda Z.; More

American Journal of Clinical Oncology. 28(4):334-339, August 2005.

Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer

Mishra, Girish; Butler, Jerome; Ho, Coty; More

American Journal of Clinical Oncology. 28(4):345-350, August 2005.

Organ Preservation and Treatment Toxicity With Induction Chemotherapy Followed by Radiation Therapy or Chemoradiation for Advanced Laryngeal Cancer

Guadagnolo, Beverly A.; Haddad, Robert I.; Posner, Marshall R.; More

American Journal of Clinical Oncology. 28(4):371-378, August 2005.




Show: